Replies to post #28578 on Lexaria Bioscience Corp (LEXX)

[AgentSmith]

This is in keeping with the terms of the incentive plan.

The options are being issued under the company's shareholder approved Equity Incentive Plan whereby the exercise price of any options issued to a person holding 10% or more of the company's issued share capital must be equal to 110% of the fair market value of the company's shares.

(https://www.proactiveinvestors.com/companies/news/917966/lexaria-bioscience-says-close-to-winning-new-patent-for-its-flagship-dehydratech-technology-917966.html)